The neuronal sodium channel gene SCN8A

神经元钠通道基因SCN8A

• 批准号: 7220786
• 负责人: MIRIAM H MEISLER
• 金额: $ 3.51万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-05-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7220786
• 关键词: RNA splicing; animal genetic material tag; disease /disorder model; gene induction /repression; gene mutation; gene targeting; genetic enhancer element; genetic promoter element; genetic transcription; genetically modified animals; human genetic material tag; laboratory mouse; model design /development; molecular pathology; nervous system disorder; neurogenetics; nucleic acid sequence; protein localization; protein structure function; sodium channel

SCN8A is an abundant voltage-gated sodium channel that is expressed throughout the mammalian brain, spinal cord and peripheral nervous system. During the previous funding period we identified mutations of SCN8A in the mouse that are responsible for ataxia, dystonia, and progressive paralysis, and mutations of SCN1A in patients with GEFS+ type 2. We propose to generate new genetic models that will contribute to understanding the normal expression and pathogenic potential of neuronal sodium channels. SCN8A is localized in the nodes of Ranvier in myelinated axons and in dendrites, and in presynapatic and postsynaptic membranes in the CNS. We will identify the protein domains responsible for subcellular localization by analysis of epitope-labeled chimeric channels in transgenic mice. We will investigate the transcriptional regulation of the SCN8A gene including identification of promoter(s) and enhancer elements. We will examine the regional distribution of alternative splicing in the brain and test a candidate site for RNA editing. Large scale genomic sequence of the SCN8A gene from human, mouse and puffer fish will be obtained and compared in order to identify evolutionarily conserved coding and noncoding sequences. We will generate mice with regulated conditional inactivation of SCN8A in specific neurons by targetting loxP sites into the SCN8A gene using homologous recombination. To produce models of human polygenic disease, we will cross SCN8A mutant mice with mice carrying null alleles of functionally related proteins such as SCN2A and the sodium channel beta subunits. This work will extend our knowledge of the physiological and cellular functions of SCN8A in the CNS and PNS and its role in neurological disease.

SCN 8A是一种丰富的电压门控钠通道，在哺乳动物的大脑、脊髓和周围神经系统中表达。 在之前的资助期间，我们确定了小鼠中导致共济失调、肌张力障碍和进行性瘫痪的SCN8A突变，以及GEFS+2型患者中的SCN1A突变。 我们建议产生新的遗传模型，这将有助于了解神经元钠通道的正常表达和致病潜力。SCN 8A定位于CNS中有髓轴突和树突中的郎维氏结中以及突触前和突触后膜中。 我们将通过分析转基因小鼠中表位标记的嵌合通道来确定负责亚细胞定位的蛋白质结构域。 我们将研究SCN 8A基因的转录调控，包括鉴定启动子和增强子元件。 我们将研究选择性剪接在大脑中的区域分布，并测试RNA编辑的候选位点。 将获得来自人类、小鼠和河豚鱼的SCN 8A基因的大规模基因组序列并进行比较，以鉴定进化上保守的编码和非编码序列。 我们将通过使用同源重组将loxP位点靶向到SCN8A基因中来产生在特定神经元中具有SCN8A的调节性条件失活的小鼠。 为了产生人类多基因疾病的模型，我们将SCN8A突变小鼠与携带功能相关蛋白（如SCN2A和钠通道β亚基）的无效等位基因的小鼠杂交。 这项工作将扩展我们对SCN 8A在CNS和PNS中的生理和细胞功能及其在神经系统疾病中的作用的认识。